Abstract - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Abstract

Aortic Valve Stenosis Treatment Disparities in the Underserved JACC Council Perspectives
Asia Pacific Consensus Document on Coronary Bifurcation Interventions
Biological Versus Chronological Aging: JACC Focus Seminar
Mediterranean Diet and the Association Between Air Pollution and Cardiovascular Disease Mortality Risk
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study
Global Approach to High Bleeding Risk Patients With Polymer-Free Drug-Coated Coronary Stents: The LF II Study
Double-Kissing Culotte Technique for Coronary Bifurcation Stenting - Technical evaluation and comparison with conventional double stenting techniques
Left Ventricular Rapid Pacing Via the Valve Delivery Guidewire in Transcatheter Aortic Valve Replacement
Clinical Relevance of Functionally Insignificant Moderate Coronary Artery Stenosis Assessed by 3-Vessel Fractional Flow Reserve Measurement
The Utility of Rapid Atrial Pacing Immediately Post-TAVR to Predict the Need for Pacemaker Implantation

|<<... 155 156 157 158 159 160 161 ...>>|

Perspective

Volume 74, Issue 18, November 2019

JOURNAL：J Am Coll Cardiol.

Article Link

Aortic Valve Stenosis Treatment Disparities in the Underserved JACC Council Perspectives

W Batchelor, S Anwaruddin, L Ross et al.

3558

Keywords: aortic stenosis; health care disparities; outcomes; prevalence; TAVR

ABSTRACT

Underserved minorities make up a disproportionately small subset of patients in the United States undergoing transcatheter and surgical aortic valve replacement for aortic stenosis. The reasons for these treatment gaps include differences in disease prevalence and patient, health care system, and disease-related factors. This has major implications not only for minority patients, but also for other groups who face similar challenges in accessing state-of-the-art care for structural heart disease. The authors propose the following key strategies to address these treatment disparities: 1) implementation of measure-based quality improvement programs; 2) effective culturally competent communication and team-based care; 3) improving patient health care access, education, and effective diagnosis; and 4) changing the research paradigm that creates an innovation pipeline for patients. Only a concerted effort from all stakeholders will achieve equitable and broad application of this and other novel structural heart disease treatment modalities in the future.